 |
James Abbruzzese, MD
Chair, GI Medical Oncology, UT-MD Anderson Cancer Center
|

|
Michael Becich, MD, PHD
Chair, Biomedical Informatics, University of Pittsburgh Medical Center |
 |
William Carroll, MD
Director, NYU Cancer Institute
|

|
Graham Colditz, MD, DrPH
Associate Director, Prevention & Control, Siteman Cancer Center/Washington University
|
 |
Christopher Counter, PhD
Professor, Pharmacology/Radiation Oncology, Duke University |

|
H. Sheldon Earp, MD
Director, UNC/Lineberger Comprehensive Cancer Center |
 |
Olivera Finn, PhD
Chair, Immunology, University of Pittsburgh School of Medicine |

|
Adi Gazdar, MD
Professor, Pathology, University of Texas Southwestern Medical Center |
 |
Judith D. Goldberg, MD
Professor, Environmental Medicine, NYU Langone Medical Center |

|
Dirk Inglehart, MD
Chief, Surgical Oncology, Dana-Farber Cancer Institute |
 |
Peter Jones, PhD, DSc
Director, Norris Comprehensive Cancer Center |

|
Thomas O'Leary, PhD
Associate Director, Research Administration, Penn State Hershey Cancer Institute |
 |
David Poplack, MD
Chief, Hematology-Oncology Service, Texas Children's Cancer Center |

|
Frank Torti, MD
Director, Wake Forest Comprehensive Cancer Center |
 |
Zena Werb, PhD
Professor/Vice-Chair, Anatomy, University of California, San Francisco |

|
Cheryl Willman, MD
Director and CEO of the University of New Mexico Cancer Center |
|
Stuart Yuspa, MD
Head, In Vitro Pathogenesis Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute |